Ipsen SA

IPSEY-OTC

OTCMKTS:IPSEY

21.81
0.00 (0.00%)
Ipsen is a French pharmaceutical company headquartered in Paris, France. It develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products. It is publicly traded on the Euronext Paris as part of the SBF 120 index. Ipsen has about 5,400 employees worldwide.
More at Wikipedia

Analysis and Opinions about IPSEY-OTC

Signal
Opinion
Expert
TOP PICK
TOP PICK
February 15, 2019
Targetting oncology mostly. Small cap. Growing at a rapid rate. Debt to EBITDA is only 2x. Spending 13% of revenues on R&D, which is pretty hefty. (Analysts’ price target is $143.07)
Ipsen SA (IPSEY-OTC)
February 15, 2019
Targetting oncology mostly. Small cap. Growing at a rapid rate. Debt to EBITDA is only 2x. Spending 13% of revenues on R&D, which is pretty hefty. (Analysts’ price target is $143.07)
David Driscoll
President & CEO, Liberty International Investment Management Inc
Price
$35.100
Owned
Yes
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »